Volume 19, Issue 5 pp. 669-675

Cancer-related secondary lymphoedema due to cutaneous lymphangitis carcinomatosa: clinical presentations and review of literature

R.J. DAMSTRA MD, PHD, DERMATOLOGIST

Corresponding Author

R.J. DAMSTRA MD, PHD, DERMATOLOGIST

Nij Smellinghe Hospital, Department of Dermatology and Phlebology and Lymphology, Compagnonsplein, Drachten

R.J. Damstra, Nij Smellinghe Hospital, Department of Dermatology and Phlebology and Lymphology, Compagnonsplein 1, 9202 NN Drachten, the Netherlands (e-mail: [email protected]). Search for more papers by this author
E.A. JAGTMAN

E.A. JAGTMAN

Medical student, Nij Smellinghe Hospital, Drachten

Search for more papers by this author
P.M. STEIJLEN MD PHD

P.M. STEIJLEN MD PHD

Department of Dermatology, University Medical Centre Hospital Maastricht, the Netherlands

Search for more papers by this author
First published: 13 August 2010
Citations: 14

Abstract

DAMSTRA R.J., JAGTMAN E.A. & STEIJLEN P.M. (2010) European Journal of Cancer Care19, 669–675

Cancer-related secondary lymphoedema due to cutaneous lymphangitis carcinomatosa: clinical presentations and review of literature

Lymphoedema is a clinical condition caused by impairment of the lymphatic system, leading to swelling of subcutaneous soft tissues. As a result, accumulation of protein-rich interstitial fluid and lymphstasis often causes additional swelling, fibrosis and adipose tissue hypertrophy leading to progressive morbidity and loss of quality of life for the patient. Lymphoedema can be distinguished as primary or secondary. Lymphoedema is a complication frequently encountered in patients treated for cancer, especially after lymphadenoectomy and/or radiotherapy based on destruction of lymphatics. However, although lymphatic impairment is sometimes caused by obstructive solid metastasis, we present three cases of secondary lymphoedema with minor dermatological features without detectable solid metastasis. Sometimes this type of lymphoedema is mistakenly called malignant lymphoedema. All patients were previously treated for cancer without clinical signs of recurrence, presented with progressive lymphoedema and minor dermatological features of unknown origin. Clinical and histopathological examination of the skin revealed diffuse lymphangitis carcinomatosa, leading to secondary lymphoedema and adjustment of the therapeutic approach and prognosis. We reviewed literature on these rare presentations of cancer recurrence and recommend, where appropriate, consulting a dermatologist when discrete skin abnormalities are seen in patients with a history of cancer and developing lymphoedema.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.